Platelet function assays in stroke management: More study is needed

Stroke

Volumn 41, Issue 10, 2010, Pages 2396-2397

  Selim, Magdy H ^a   Molina, Carlos A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE;

ANTICOAGULANT THERAPY; BLEEDING; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FUNCTION TEST; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT SURVEY; STROKE; THROMBOCYTE FUNCTION; BLOOD CLOTTING PARAMETERS;

HUMANS; PLATELET FUNCTION TESTS; STROKE;

EID: 77957990550     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.593160     Document Type: Short Survey

References (6)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myo-cardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
2. Johnson ES, Lanes SF, Wentworth CE, Satterfield MH, Abebe BL, Dicker LW. A meta regression analysis of the dose-response effect of aspirin on stroke. Arch Intern Med. 1999;159:1248-1253.
3. Algra A, Van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry. 1996; 60:197-199.
4. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364: 331-337.
5. A randomised, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329-1339.
6. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.